Senior Financial Analyst

Full-time

Senior Financial Analyst — VBC/Bus Dev

This position consolidates that recurring demand into a single, dedicated senior-analyst seat spanning three areas: value-based-care financial performance management; M&A and corporate-development analytics; and clinic, lab, and integration finance support for the VP of Finance's expanding operating mandate. It is designed to give the CFO and executive team reliable, repeatable monthly visibility into VBC and operating performance; to strengthen diligence on both fee-for-service and value-based acquisition targets;

and to relieve senior finance and population-health leaders of recurring analytical preparation — freeing them to operate at the right altitude, and moving the VP of Finance from performing the analytical work to leading it.

Reports to:

Vice President of Finance

Internal customers:
Population Health and New Markets & Growth

Recurring executive deliverable:
Monthly VBC financial-performance roll-up to the CFO

Structure:
Individual contributor; no direct reports.

• Own and maintain the financial statements for each of SPCP's value-based-care programs
• Produce a standardized monthly roll-up of VBC financial performance against accruals for the CFO and executive team
• Build and maintain Population Health program P&Ls
• Partner with Population Health leadership to translate program results into financial performance and to flag emerging variances early
• Provide analysis that helps Population Health identify performance-improvement opportunities — program-level margin, cost and utilization drivers, and which contracts or member cohorts are running ahead of or behind target — so results inform action, not just reporting
• Support financial scenario analysis for value-based contract decisions (renewals, new payer contracts, and changes in risk level), and benchmark performance across programs to surface where SPCP's own VBC capabilities can be strengthened

• Support financial diligence from initial opportunity assessment through close, including fee-for-service and value-based financial assessments of targets.
• Build and maintain acquisition valuation and business-case models
• Quantify and validate revenue, cost, and value-based-care synergies during diligence.
• Assess a target's value-based-care position — attributed lives, risk-contract mix, and quality performance — and model the incremental VBC value of folding it into SPCP's existing contracts.
• Develop a repeatable framework to tie value to a target's VBC results, and produce diligence-ready VBC performance packets — including a read on the maturity of the target's VBC capabilities.
• Develop standardized diligence frameworks, financial models, and KPI dashboards to improve transaction execution.
• Prepare financial findings and investment-committee materials for review with the VP of Finance.
• Partner with Corporate Development, Strategy, Operations, FP&A, and clinical leadership throughout the M&A lifecycle.
• Monitor post-close performance, synergy realization, and ROI against the original underwriting
• Provide incremental analytical support to New Markets & Growth as deal flow requires.

• Support financial performance management across the clinic and lab operating footprint; producing location- and practice-level P&L views, tracking performance against plan, and flagging emerging issues.
• Analyze clinic- and lab-level performance trends — volume, revenue-per-visit, cost, and margin drivers — and translate them into financial implications and recommended actions.
• Support financial analysis of the lab operation — utilization, contribution, cost-per-test, and its financial relationship to the clinics it serves.
• Support provider-capacity, visit-volume, and staffing analyses as they bear on clinic and lab financial performance.
• Support finance integration of newly acquired practices — onboarding them into reporting structures, aligning their financials to SPCP definitions, and tracking integration progress against the deal model.
• Prepare executive-ready materials — summaries, dashboards, and board or investor inputs — that f